Latest Mifepristone Legal Debates Raise More Questions, Confusion for Health Care Professionals

healthcareU.S. Supreme Court
Written By Ron Lanton

Lanton Law speak with Pharmacy Times about the Supreme Court’s decision on Mifepristone. Click here for the interview.

Ron Lanton
Previous

Lanton Law Quoted in Pharmacy Times Article "FDA Approves First Nonprescription Daily Birth Control Pill"
Next

Lanton Law Teams Up With MSHP on Health Promotion Screening Bill